Search

everythinglearnresearchcommunity

for

Search:↓

Overweight women with PCOS have higher levels of certain hormones that could indicate a higher risk of heart and metabolic problems.

Thyroid hormones and androgens affect gene expression in frog reproductive organs differently between males and females.

The method effectively identifies and measures seven banned substances in cosmetics.

The safety of placental and umbilical extracts in cosmetics is uncertain, requiring more research.

COVID-19 patients may experience temporary hair loss, mainly in women, which is likely reversible.

Baicalin may help reduce excessive male hormone levels in PCOS.

Hormone therapy in transgender women can affect hair growth and acne, and there are specific skin issues related to gender-affirming surgery, but more research is needed on their dermatological health.

New hormonal treatments for enlarged prostate show promise for safer, effective non-surgical options.

ERβ has potential in treating prostate cancer and neurodegenerative diseases, but human studies are needed before clinical use.

Men are more likely to have severe respiratory viral infections like COVID-19 due to hormonal and genetic differences, while women generally have stronger immune responses.

Sex steroids, especially progesterone, can slow down the growth of mouse melanoma cells.

Testosterone therapy seems safe for short-term use in postmenopausal women with low sexual desire, but more research on long-term effects is needed.

The document concludes that awareness and understanding of hidradenitis suppurativa are increasing, but effective treatments are still needed.

Bisphenol-A (BPA) increases connections between brain cells and boosts their activity, but it blocks the effects of a male hormone on brain cell plasticity.

Gender differences affect allergy prevalence, severity, and response to environmental toxins, with women often more affected than men.

The document concludes that hormone therapy is essential for treating gender dysphoria, with specific drugs and monitoring protocols recommended for safety and effectiveness.

Topical minoxidil improves hair loss in 80% of women with breast cancer undergoing endocrine therapy.

The document concludes that treating androgen excess needs patience, managing expectations is important, and many drugs used are not officially approved, suggesting cosmetic options for mild cases.

COVID-19 may affect male fertility and women might have better outcomes due to hormonal and immune differences.

Blackcurrant extract may help reduce hair loss by promoting stem cell activity in hair follicles.

Topical minoxidil is the most promising treatment for male pattern hair loss, but more research is needed to confirm its effectiveness and safety.

The research found genes that change during cashmere goat hair growth and could help determine the best time to harvest cashmere.

Finasteride treatment changes urine metabolomics and steroid signatures, potentially monitoring effectiveness but may cause sexual side effects.

Testosterone treatment can improve sexual function and bone density in women but may have adverse effects and requires more research on safety and guidelines.

Flutamide, an antiandrogen, has minimal impact on female rat endocrine systems and does not significantly change their reproductive cycles.

Transdermal testosterone can improve sexual desire in postmenopausal women but lacks long-term safety data and is not FDA-approved for this use.

Exemestane is effective and safe for treating certain breast cancers, with mild side effects, but needs more research on long-term effects.

The method can measure multiple steroids in human hair to study long-term steroid metabolism, especially in newborns and children.

Finasteride, a hair loss medication, may be linked to stroke in young men.

A man got brown patches on his skin (melasma) after taking finasteride, a hair loss treatment.